Presenter: Tamas Fulop (Université de Sherbrooke, Canada)
Presentation Type: Oral Presentation (Virtual)
Title: Potential disease-modifying treatments for neurocognitive disorders
🔬 Presentation Highlights
∙ Focus: Investigating innovative therapeutic strategies for Alzheimer's disease, one of the most challenging global neurodegenerative disorders.
∙ Clinical Challenge: Despite recent monoclonal antibody therapies, reliable disease-modifying treatments remain limited.
∙ Research Approach: Evaluation of existing drugs for repurposing in modulating key pathological hallmarks of Alzheimer’s disease.
∙ Drugs Studied: The anti-retroviral drug Raltegravir and SGLT2 inhibitors such as Empagliflozin and Dapagliflozin.
∙ Cellular Models: Experiments conducted using H4 neuroglioma and HMC3 microglia cell models to study molecular alterations induced by amyloid-beta.
∙ Key Findings:
Raltegravir significantly reduced Tau phosphorylation (p-Tau181) and modulated key kinases and phosphatases.
Reduced inflammatory signaling through downregulation of the NLRP3 inflammasome pathway.
SGLT2 inhibitors decreased oxidative stress and neuroinflammatory responses triggered by amyloid-beta.
∙ Neuroprotective Effects: Gliflozins improved cell viability and reduced apoptosis in neuronal models.
∙ Therapeutic Potential: These findings suggest promising drug-repurposing strategies for modifying disease progression in Alzheimer’s disease.
∙ Research Outlook: Provides preliminary mechanistic insights supporting further clinical exploration of these treatments.
🌍 Join the Conference
Event: International Conference on Neurology and Neuroscience
📅 March 23–25, 2026
📍 Singapore & Online
🌐 Event Website: https://neurocareconference.com/
🧬 Submit Abstract: https://neurocareconference.com/abstract-submission
📝 Register: https://neurocareconference.com/register
💬 Connect with Global Experts in Neuroscience and Neurology to Explore the Latest Research, Innovations, and Clinical Advances.
#Neurology #Neuroscience #AlzheimersResearch #NeurodegenerativeDiseases #BrainHealth #CognitiveDisorders #NeuroscienceConference #NeurologyConference #MedicalResearch #BrainScience #NeuroInnovation #Neurocare2026 #SingaporeConference #HealthcareInnovation #GlobalResearch #ScientificConference 🧠🔬
No comments:
Post a Comment